All News

Targeted therapies have changed non-small cell lung cancer care, but new side effects, like weight gain, are emerging, says Dr. Lorenzo Belluomini.

Lymphoma is a treatable cancer of the immune system; early diagnosis and personalized treatment with chemo and radiation often lead to a cure.

Dr. Jacob A. Sands shares how patients with lung cancer can interpret clinical trial results and how these findings translate to treatment decisions.

The NY Giants Legend To Celebrate Being Cancer Free At The NFL Giants Crucial Catch Game September 28th at MetLife Stadium.

Inluriyo, an oral therapy for ER+, HER2– metastatic breast cancer with ESR1 mutations, offers a new treatment option after prior endocrine therapy.

Tending my garden and observing nature teaches me resilience, presence, and growth, helping me carry joy and sorrow while living with Lynch syndrome.

Women with a history of cervical cancer are nearly twice as likely to develop anal cancer as members of the general population, according to researchers.

A study found that iberdomide with Darzalex and dexamethasone helped more patients with multiple myeloma reach no signs of cancer after treatment.

Dr. David A. Taub sat down with CURE for an interview in honor of Prostate Cancer Awareness Month, observed annually each September.

As a 12-year survivor of myelodysplastic syndrome, I’ve learned that each of us faces cancer our own way, and in the end, we can say we lived life our way.

ACRO announced that the Special Distinction in Stereotactic Radiotherapy will be made available to radiation oncology practices accredited through ACR®.

The FDA granted priority review to an sBLA for first-line treatment with Enhertu plus Perjeta in unresectable or metastatic HER2-positive breast cancer.

Pancreatic cancer remains one of the deadliest cancers because it is often detected at an advanced stage when treatment options are limited.

The FDA grants fast track status to alnodesertib plus low-dose irinotecan for third-line metastatic colorectal cancer with ATM deficiency.

After a stage 3b rectal cancer diagnosis, one patient endured radiation, chemotherapy, surgery, and complications, relying on resilience, advocacy and support.

I’ve lived 22 years beyond my breast cancer diagnosis, and each day I honor survival with gratitude, wellness, and hope for myself and others.

Dr. Daniel P. Petrylak discussed recent developments in prostate cancer care, emphasizing the importance of genetic testing and personalized treatment.

Dr. Christina Cho explains that a strong transplant program provides advanced treatments along with a supportive team for patients with blood cancers.

LiveLung announced the launch of its new Chaplain Program.

This Prostate Cancer Awareness Month, join our free Men's Health Event.

Going through breast cancer has pushed me to do things I never thought I would.

This Prostate Cancer Awareness Month, a first-in-the-nation trial offers hope by using a targeted therapy before surgery to stop recurrence in its tracks.

CURE spoke with Amanda Davis at the John Theurer Cancer Center in Hackensack, New Jersey.

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United.

Tecvayli and Darzalex demonstrated meaningful clinical efficacy in transplant-eligible patients with newly diagnosed multiple myeloma.

Dr. Prithviraj Bose discussed the current treatment landscape for myeloproliferative neoplasms, a group of rare blood cancers; he focused on myelofibrosis.

Molecular testing helps distinguish kidney cancer subtypes, ensuring patients get accurate diagnoses and treatment plans, avoiding unnecessary surgery.

Patients need long-term monitoring after gastrointestinal stromal tumor surgery, with some requiring extra treatment or genetic testing to lower recurrence risk.